Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
Characterization of a novel myeloma cell line, MM.1R E Goldman-Leikin, H R Salwen, C V Herst, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 1999
Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissueJ R Schroeder, A J Saah, R F Ambinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council StudyS T Rosen, A M Zimmer, R Goldman-Leikin, et al.
Blood|March 7, 1998
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory studyJ N Winter, J Andersen, J C Reed, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 1999
Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphomaJ R Schroeder, A J Saah, D R Hoover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
Pageof 9